17α-hydroxyprogesterone caproate for prevention of recurrent preterm birth: Impact of gestational age at previous delivery
Authors:
- Paul J. MeisPMPaul J. Meis
- Elizabeth A. ThomETElizabeth A. Thom
- Baha SibaiBSBaha Sibai
- Mitchell P. DombrowskiMDMitchell P. Dombrowski
- Atef H. MoawadAMAtef H. Moawad
- John C. HauthJHJohn C. Hauth
- Jay D. IamsJIJay D. Iams
- Michael W. VarnerMVMichael W. Varner
- Steve N. CaritisSCSteve N. Caritis
- Mary J. O'SullivanMOMary J. O'Sullivan
- Menachem MiodovnikMMMenachem Miodovnik
- 1 September 2005
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 193 (3) , 1127-1131
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Child Health and Human Development
This publication has 7 references indexed in Scilit:
- Living with the Past: Evolution, Development, and Patterns of DiseaseScience, 2004
- Prevention of Recurrent Preterm Delivery by 17 Alpha-Hydroxyprogesterone CaproateNew England Journal of Medicine, 2003
- Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind studyAmerican Journal of Obstetrics and Gynecology, 2003
- The Preterm Prediction Study: Effect of gestational age and cause of preterm birth on subsequent obstetric outcomeAmerican Journal of Obstetrics and Gynecology, 1999
- Recurrence of Gestational Age in Sibships: Implications for Perinatal MortalityAmerican Journal of Epidemiology, 1999
- The Preterm Prediction Study: Recurrence risk of spontaneous preterm birthAmerican Journal of Obstetrics and Gynecology, 1998
- Gap junction formation in myometrium: control by estrogens, progesterone, and prostaglandinsAmerican Journal of Physiology-Cell Physiology, 1980